Article
Loss of KAI1 expression in the progression of colorectal cancer.
Cancer research - 15 Nov 1999
Lombardi D P, Geradts J, Foley J F, Chiao C, Lamb P W, Barrett J C
Abstract excerpt
The transmembrane 4 superfamily member KAI1 (CD82) has been shown to inhibit pulmonary metastases in experimental metastasis models of prostate cancer and melanoma. KAI1 expression is decreased in the progression of common solid epithelial tumors of adulthood, including lung, prostate, breast, esophageal, gastric, pancreatic, and bladder cancers. The purpose of our study was to investigate KAI1 expression in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
